Biovica participates at the AACR annual meeting 2015, 18-22 April in Philadelphia

The AACR Annual Meeting 2015 will highlight the latest discoveries in cancer research and will provide an opportunity for investigators from all over the world to meet, interact, and share their insights.
The American association for cancer research (AACR) annual meeting is one of the largest gatherings of cancer researchers and oncologists in the world. The meeting will take place between the 18th and 22nd of April in Philadelphia and Biovica is attending the meeting to expand its extensive collaboration and research network and to share our latest insights from ongoing clinical trials.

“The AACR annual meeting is a very exciting event for Biovica. We are looking forward to meet our research partners and also to expand our collaborations with other oncologists and pharmaceutical companies. Our ambition is to provide our partners with access to the DiviTum™ technology as a tool for predicting and evaluating drug efficacy for new cancer drugs. By doing so we aim to improve the preclinical and clinical development of new drugs so that cancer patients can receive the best possible care.”says Magnus Neumüller, Research Director of Biovica.

Meet Biovica at AACR

If you wish to meet us at the AACR annual meeting please do not hesitate to contact us at bd@biovica.com.

Read more about AACR

Biovica was founded in 2009 and has built an extensive portfolio of clinical trials for it’s DiviTum technology through international collaboration with academia and the pharmaceutical industry. As of today DiviTum has 10 peer-reviewed publications, 13 on-going clinical trials and a promising pipeline of new studies and projects.

2015-04-07T08:59:04+00:00 April 7th, 2015 08:59|News|